By 22-Point Margin, Voters Favor Obamacare’s Repeal
It would be a major understatement to say that Obamacare has had a bad spring. Support for the President’s signature health reform act has fallen dramatically.
This author has not written his bio yet.
But we are proud to say that Joe Miller contributed 36670 entries already.
It would be a major understatement to say that Obamacare has had a bad spring. Support for the President’s signature health reform act has fallen dramatically.
Some call it wishful thinking, but President Barack Obama has all but declared an end to the global war on terror.
Here’s an indication of how burdensome student loans have become: About one-third of millennials say they would have been better off working, instead of going to college and paying tuition.
One year after a devastating flesh eating bacteria attack, Aimee Copeland has regained independence and is encouraging Americans everywhere.
It happens in China routinely. It frequently happened in the old Soviet Union. Undoubtedly in North Korea, although generally there’s no one around to witness it. But in the United States? It happens here, too, apparently.
A federal judge has ruled that the office of America’s self-proclaimed toughest sheriff systematically singled out Latinos in its trademark immigration patrols, marking the first finding by a court that the agency racially profiles people.
The Irish should be remembered this Memorial Day. The unique blend of the Irish and their invaders created a hybrid of warrior that has filled the ranks of many armies around the world.
A female suicide bomber identified as a widow of two killed Islamists blew herself up in the southern Russian region of Dagestan on Saturday injuring at least 12, including two children and five police officers, police said.
French anti-terrorism investigators were searching Sunday for a man who stabbed a soldier in the throat in the commercial district of La Defense outside Paris.
Despite expiring patents on blockbuster drugs and a wave of new regulation from Obamacare, the pharmaceutical industry will reap between “$10 billion and $35 billion in additional profits over the next decade,” a new analysis shows.
